Research progress of proteolysis-targeting chimeras in viral hepatitis drug discovery

Proteolysis Targeting Chimera (PROTAC) is an innovative drug discovery strategy that utilizes bifunctional small molecules to bring a target protein (POI) into proximity with an E3 ubiquitin ligase, thereby inducing ubiquitination of the pathogenic protein and its subsequent degradation by the prote...

Descrición completa

Detalles Bibliográficos

Principais autores:	Xiaofei Hao, Yanli Wang, Gang Huang, Chaoyang Lin, Peng Zhao, Wubin Zhi, Xiankai Li, Peng Qi, Peng Liu
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-06-01
Series:	Frontiers in Chemistry
Assuntos:	antiviral drugs fluorine hepatitis virus PROTAC resistance
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fchem.2026.1810498/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!